Abbott Laboratories (ABT) FCF Payout Ratio (2009 - 2026)

Abbott Laboratories has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 1.2 for Q1 2026.

• FCF Payout Ratio for Q1 2026 came in at 1.2, up 9.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.57 (down 3.23% YoY), and the FY2025 annual result was 0.56, down 7.85% from the prior year.
• FCF Payout Ratio came in at 1.2 for Q1 2026 at Abbott Laboratories, up from 0.39 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.53 in Q1 2024 to a low of 0.36 in Q3 2022.
• The 5-year median for FCF Payout Ratio is 0.48 (2022), against an average of 0.71.
• Across the five-year window, FCF Payout Ratio surged 213.66% in 2023 and sank 47.34% in 2024, its largest moves.
• Abbott Laboratories' FCF Payout Ratio stood at 0.48 in 2022, then decreased by 18.9% to 0.39 in 2023, then climbed by 14.66% to 0.45 in 2024, then dropped by 12.05% to 0.39 in 2025, then jumped by 205.61% to 1.2 in 2026.
• The last three FCF Payout Ratio figures came in at 1.2 (Q1 2026), 0.39 (Q4 2025), and 0.45 (Q3 2025), per Business Quant data.